EDGAR Verified
Primary Source · SEC.gov

EquityZen Growth Technology Fund LLC - Series 1831

CIK 0001993756Single-Deal SPV2024 vintage506(b), 3(c)(1)

Raised

$298K

Investors

10

Min Invest

$5,019

AltStreet Analysis

·

Generated from EDGAR primary sources

EquityZen Growth Technology Fund LLC - Series 1831 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC and Philip Haslett, raising $298K from 10 investors under Rule 506(b) and Section 3(c)(1). The offering has a $5K minimum investment and is part of EquityZen's pre-IPO access platform, which operates over 1,800 related series vehicles.

This pre-IPO fund follows the typical EquityZen model: a sub-$1M raise with accessible minimums ($5K) under the private 506(b) exemption and 3(c)(1) investment company exclusion. The structure and scale are consistent with single-company SPVs designed to pool capital for access to shares of private growth-stage companies.

Data Flags

generalPart of a high-volume series structure with 1,889 related entities on the EquityZen platform; individual series filings share uniform templates including blank states of solicitation and industry group fields

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0001993756
Entity NameEquityZen Growth Technology Fund LLC - Series 1831
Exemption506(b), 3(c)(1)
First Sale Date
Filing DateMarch 19, 2024
Accession Number0001993756-24-000001
Total Amount Sold$298K
Total Investors10
Minimum Investment$5,019
Securities TypeEquity, Pooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

EquityZen Advisors LLC

Executive Officer, Director · New York, NY

Philip Haslett

Executive Officer, Director · New York, NY

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.